Genotype and phenotype in carriers of germline TP53 mutations

被引：0
|
作者：
Varley, J
Evans, DGR
Kelsey, AM
Birch, JM
机构：
[1] Paterson Inst Canc Res, CRC, Canc Genet Grp, Manchester M20 9BX, Lancs, England
[2] St Marys Hosp, Dept Med Genet, Manchester M13 0JH, Lancs, England
[3] Royal Manchester Childrens Hosp, Dept Histopathol, Manchester M27 1HA, Lancs, England
来源：
JOURNAL OF MEDICAL GENETICS | 2000年 / 37卷
关键词：
D O I：
暂无
中图分类号：
Q3 [遗传学];
学科分类号：
071007 ; 090102 ;
摘要：
SP32
引用
收藏
页码：S22 / S22
页数：1
相关论文
共 50 条
  • [21] GERMLINE TP53 MUTATIONS AND SINGLE NUCLEOTIDE POLYMORPHISMS IN CHILDREN
    Valva, Pamela
    Becker, Pablo D.
    Streitemberger, Patricia
    Lombardi, Mercedes Garcia
    Rey, Guadalupe
    Guzman, Carlos A.
    Victoria Preciado, Maria
    [J]. MEDICINA-BUENOS AIRES, 2009, 69 (02) : 143 - 147
  • [22] Clinical implications of germline mutations in breast cancer: TP53
    Schon, Katherine
    Tischkowitz, Marc
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2018, 167 (02) : 417 - 423
  • [23] The TP53 gene promoter is not methylated in families suggestive of Li-Fraumeni syndrome with no germline TP53 mutations
    Finkova, Alena
    Vazna, Alzbeta
    Hrachovina, Ondrej
    Bendova, Sarka
    Prochazkova, Kamila
    Sedlacek, Zdenek
    [J]. CANCER GENETICS AND CYTOGENETICS, 2009, 193 (01) : 63 - 66
  • [24] Effects of MDM2, MDM4 and TP53 Codon 72 Polymorphisms on Cancer Risk in a Cohort Study of Carriers of TP53 Germline Mutations
    Fang, Shenying
    Krahe, Ralf
    Lozano, Guillermina
    Han, Younghun
    Chen, Wei
    Post, Sean M.
    Zhang, Baili
    Wilson, Charmaine D.
    Bachinski, Linda L.
    Strong, Louise C.
    Amos, Christopher I.
    [J]. PLOS ONE, 2010, 5 (05):
  • [25] Choroid Plexus Carcinomas With TP53 Germline Mutations: Management and Outcome
    Li, Yanong
    Liu, Hailong
    Li, Tandy
    Feng, Jin
    He, Yanjiao
    Chen, Li
    Li, Chunde
    Qiu, Xiaoguang
    [J]. FRONTIERS IN ONCOLOGY, 2021, 11
  • [26] TP53 germline and somatic mutations in a patient with fibrolamellar hepatocellular carcinoma
    Andrade, Raissa C.
    de Lima, Maria A. F. D.
    de Faria, Paulo A. S.
    Vargas, Fernando R.
    [J]. FAMILIAL CANCER, 2018, 17 (01) : 119 - 122
  • [27] TP53 germline and somatic mutations in a patient with fibrolamellar hepatocellular carcinoma
    Raissa C. Andrade
    Maria A. F. D. de Lima
    Paulo A. S. de Faria
    Fernando R. Vargas
    [J]. Familial Cancer, 2018, 17 : 119 - 122
  • [28] Germline TP53 mutations: the predominant genetic cause of adrenocortical carcinoma
    Renaux-Petel, M.
    Charbonnier, F.
    Tournier, I.
    Lienard, G.
    Bou, J.
    Kasper, E.
    Leheup, B.
    Mansuy, L.
    Guerrini-Rousseau, L.
    Brugieres, L.
    Liard-Zmuda, A.
    Baert-Desurmont, S.
    Frebourg, T.
    Bougeard, G.
    [J]. EUROPEAN JOURNAL OF HUMAN GENETICS, 2019, 27 : 1105 - 1105
  • [29] NO GERMLINE TP53 MUTATIONS DETECTED IN FAMILIAL AND BILATERAL TESTICULAR CANCER
    HEIMDAL, K
    LOTHE, RA
    LYSTAD, S
    HOLM, R
    FOSSA, SD
    BORRESEN, AL
    [J]. GENES CHROMOSOMES & CANCER, 1993, 6 (02): : 92 - 97
  • [30] Characterization of germline TP53 splicing mutations and their genetic and functional analysis
    J M Varley
    C Attwooll
    G White
    G McGown
    M Thorncroft
    A M Kelsey
    M Greaves
    J Boyle
    J M Birch
    [J]. Oncogene, 2001, 20 : 2647 - 2654
12345